Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic
February 02, 2021 04:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitoring.
The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report. What is the impact of the COVID pandemic on the Liquid Biopsy market? This report provides a detailed analysis.
Circulating Tumor Cells? Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market s
When genetic data meets marketing
Researchers from The Wharton School of the University of Pennsylvania published a new paper in the Journal of Marketing that assesses the implications of the growth of private genetic testing for the field of marketing and evaluates ethical challenges that arise. The researchers review past research in the field of behavioral genetics and use these findings to incorporate genetic influences into existing consumer behavior theory. They then survey potential uses of genetic data for marketing strategy and research, and raise concerns regarding significant ethical challenges that arise from unique features of genetic data.
The study, forthcoming in the Journal of Marketing, is titled Genetic Data: Potential Uses and Misuses in Marketing and is authored by Remi Daviet, Gideon Nave, and Jerry Wind.